Gyalatx
Barcelona, ES · Founded 2020 · 8 employees on LinkedIn · 2 known investors
Find your way into Gyalatx
Sign up to see every warm intro you have to Gyalatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gyalatx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gyala Therapeutics develops autologous immunotherapy based on CAR-T technology targeting CD84 for cancer treatment. The company is a technology-based enterprise supported by Spanish government research and innovation programs.
Investors · 2
Frequently asked questions
- What does Gyalatx do?
- Gyala Therapeutics develops autologous immunotherapy based on CAR-T technology targeting CD84 for cancer treatment. The company is a technology-based enterprise supported by Spanish government research and innovation programs.
- Who are Gyalatx's investors?
- Gyalatx's investors include CDTI, Invivo Capital Partners.
- Where is Gyalatx headquartered?
- Gyalatx is headquartered in Barcelona, ES.
